Iovance Biotherapeutics, Inc. short interest in 2021
In 2021, Iovance Biotherapeutics, Inc.'s disclosed short interest ran from 10.46% of shares outstanding on 15 Jan 2021 to 7.95% on 31 Dec 2021, a change of -2.51 percentage points. The year's high was 14.61% on 28 May 2021 and its low 7.95% on 31 Dec 2021, averaging 10.97% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.52 days on 12 Feb 2021. Full history: Iovance Biotherapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 10.46% (15 Jan 2021)
- End of year
- 7.95% (31 Dec 2021)
- Change
- -2.51 pp
- High
- 14.61% (28 May 2021)
- Low
- 7.95% (31 Dec 2021)
- Average
- 10.97%
- Highest days to cover
- 16.52 (12 Feb 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 10.46% | 13.58 | |
| 29 Jan 2021 | 9.58% | 11.52 | |
| 12 Feb 2021 | 8.71% | 16.52 | |
| 26 Feb 2021 | 9.53% | 11.13 | 10-K filed, results (8-K) |
| 15 Mar 2021 | 10.14% | 7.80 | |
| 31 Mar 2021 | 14.53% | 8.12 | |
| 15 Apr 2021 | 13.66% | 11.15 | |
| 30 Apr 2021 | 12.92% | 11.93 | |
| 14 May 2021 | 13.16% | 8.62 | 10-Q filed, results (8-K) |
| 28 May 2021 | 14.61% | 2.22 | |
| 15 Jun 2021 | 13.55% | 5.22 | |
| 30 Jun 2021 | 11.60% | 7.12 | |
| 15 Jul 2021 | 11.68% | 10.23 | |
| 30 Jul 2021 | 11.28% | 11.41 | |
| 13 Aug 2021 | 11.08% | 10.16 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 10.86% | 12.23 | |
| 15 Sep 2021 | 10.14% | 10.55 | |
| 30 Sep 2021 | 9.58% | 10.94 | |
| 15 Oct 2021 | 9.94% | 13.07 | |
| 29 Oct 2021 | 9.71% | 13.96 | |
| 15 Nov 2021 | 10.07% | 6.23 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 9.95% | 8.43 | |
| 15 Dec 2021 | 8.54% | 7.35 | |
| 31 Dec 2021 | 7.95% | 7.68 |
See also: Iovance Biotherapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.